Edward Kowlowitz, MD
Interventional Pain Medicine · Indianapolis, INNPI 1972590529
Payments from drug & device makers
Across 370 payments — averaging $41.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$2K
- Vertiflex, Inc.$2K
- Medtronic$2K
- Vertos Medical, Inc.$904
- AbbVie$841
- plus $4K from 36 others
What the payments were for
- Travel & lodging$1,4169%
- Food & beverage$13,88491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,545
- WaveWriter Alpha Prime 16$1,086
- mild Device Kit$772
- GENERAL PAIN MANAGEMENT$628
- Proclaim IPG$466
- INTELLIS ADAPTIVESTIM$398
- VANTA ADAPTIVESTIM$343
- Evoke$306
- Proclaim Family of SCS IPGs$289
- SYNCHROMED$255
- AIMOVIG$245
- NEUROSTAR TMS THERAPY SYSTEM$157
- Prospera$151
- Penta SCS Leads$149
- ReActiv8$146
- Neuromodulation Dspsbls and Accs$134
- SYNCHROMEDII$131
- SPECTRA WAVEWRITER$124
- Octrode SCS Leads$124
- BELBUCA$124
How this compares
$15,300 in reported general payments places this provider in the 85th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $1,137 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $883 |
| Gabapentin | 19 | $207 |
| Cyclobenzaprine Hcl | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Indianapolis
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Ashley TolbertIndianapolis$15K
- Kristin GossIndianapolis$7K
- Caroline AsavaIndianapolis$3K
- Keiona WallerIndianapolis$3K
- Michael DorwartIndianapolis$3K
- Dena SeifertIndianapolis$2K
- David RatzmanIndianapolis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.